Gideon Capital Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-9,090
Closed -$216K 321
2019
Q1
$216K Buy
+9,090
New +$207K 0.08% 340
2017
Q4
Sell
-21,199
Closed -$514K 327
2017
Q3
$514K Buy
21,199
+3,670
+21% +$97.7K 0.51% 41
2017
Q2
$432K Sell
17,529
-130
-0.7% -$2.75K 0.48% 71
2017
Q1
$383K Sell
17,659
-37,395
-68% -$760K 0.23% 168
2016
Q4
$821K Buy
+55,054
New +$794K 0.52% 16

Other funds holding EXEL

Gideon Capital Advisors's EXEL Position: Q2 2019 in Review

Gideon Capital Advisors sold out of Exelixis (EXEL) in Q2 2019, closing a stake of 9,090 shares — an estimated $216K sold.

Gideon Capital Advisors first reported a position in EXEL in Q4 2016 and held it in 5 quarters. The position peaked at $821K in Q4 2016. 346 funds tracked by Wall St. Rank hold EXEL as of Q2 2019.

  • Gideon Capital Advisors reported no remaining Exelixis position as of Q2 2019 after selling out during the quarter.
  • Gideon Capital Advisors sold 9,090 Exelixis shares in Q2 2019, an estimated $216K.
  • Gideon Capital Advisors first reported a position in Exelixis in Q4 2016 and held it in 5 quarters.
  • Gideon Capital Advisors's Exelixis position peaked at $821K in Q4 2016.
  • 346 funds tracked by Wall St. Rank held Exelixis as of Q2 2019.

Based on Gideon Capital Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.